Although the risk of serious illness from COVID-19 for people with HIV is not known, people with HIV may have concerns and questions related to their risk.
This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available.
At the present time, we have no specific information about the risk of COVID-19 in people with HIV.
Older adults and people of any age who have a serious underlying medical condition might be at higher risk for severe illness, including people who are immunocompromised. The risk for people with HIV getting very sick is greatest in:
There is currently no vaccine to prevent COVID-19. The best way to prevent getting sick is to avoid exposure to the virus.
People with HIV should take everyday preventive actions to help prevent the spread of COVID-19.
People with HIV should also continue to maintain a healthy lifestyle. This includes:
Staying healthy helps your immune system fight off infection should it occur.
If you have HIV and are taking your HIV medicine, it is important to continue your treatment and follow the advice of your health care provider. This is the best way to keep your immune system healthy.
Call your health care provider if you develop symptoms that could be consistent with COVID-19. Discuss how to get evaluated and how to avoid potentially exposing others to COVID-19.
Learn more about COVID-19 and what to do if you get sick.
Nearly half of people in the United States with diagnosed HIV are aged 50 years and older. People with HIV also have higher rates of certain underlying health conditions. Both increased age and these conditions can increase their risk for more severe illness if people with HIV get COVID-19, especially people with advanced HIV.
Steps that people with HIV can take to prepare in addition to what is recommended for everybody:
Drug shortages or anticipated problems with HIV medicine have not been identified.
The U.S. Food and Drug Administration (FDA) is closely monitoring the drug supply chain as the COVID-19 outbreak has the potential to disrupt the supply of medical and pharmaceutical products in the United States.
The National Alliance of State and Territorial AIDS Directors (NASTAD) has also remained in contact with the major manufacturers of HIV medicine as many of these products rely on ingredients produced in China.
As of March 10, 2020, there were no reports of manufacturing concerns or supply shortages.
Learn more about the FDA’s response to COVID-19.
For the latest CDC travel recommendations, visit CDC’s COVID-19 travel information page.
Minimizing stigma and misinformation about COVID-19 is very important. People with HIV have experience in dealing with stigma and can be allies in preventing COVID-19 stigma. Learn how you can reduce stigma and help prevent the spread of rumors about COVID-19.